Finance

Lists
Why is 6541 up 3,49%?
Dive Deeper
6541:TPE
Tanvex Biopharma Inc
31,10 NT$
+3,49%
(+1,05) 1D
20 қаз., 13:30:07 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6541...
Open
29,85 NT$
High
31,40 NT$
Low
29,85 NT$
Mkt. cap
8,25 млрд
Avg. vol.
469,00 м.
Volume
422,58 м.
52-wk high
65,50 NT$
52-wk low
29,60 NT$
EPS
-5,56 NT$
Shares outstanding
242,67 млн
No. of employees
215
Open
29,85 NT$
High
31,40 NT$
Low
29,85 NT$
Mkt. cap
8,25 млрд
Avg. vol.
469,00 м.
Volume
422,58 м.
52-wk high
65,50 NT$
52-wk low
29,60 NT$
EPS
-5,56 NT$
Shares outstanding
242,67 млн
No. of employees
215
News stories
From web sources and news partners
About Tanvex Biopharma Inc
CEO-
Employees215
Founded2011
Headquarters-
Sector-
Websitetanvex.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
125,34 млн
178,95 млн
132,83 млн
220,44 млн
Cost of goods sold
287,65 млн
422,66 млн
399,36 млн
446,37 млн
Cost of revenue
287,65 млн
422,66 млн
399,36 млн
446,37 млн
Research and development expenses
19,27 млн
13,26 млн
24,24 млн
19,86 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104,56 млн
104,26 млн
108,51 млн
121,17 млн
Operating expense
123,98 млн
129,86 млн
133,70 млн
141,15 млн
Total operating expenses
411,63 млн
552,52 млн
533,06 млн
587,52 млн
Operating income
-286,29 млн
-373,57 млн
-400,23 млн
-367,07 млн
Other non operating income
-372,00 м.
44,99 млн
188,00 м.
418,00 м.
EBT including unusual items
-273,50 млн
-420,53 млн
-388,70 млн
-382,53 млн
EBT excluding unusual items
-294,27 млн
-305,62 млн
-388,70 млн
-382,53 млн
Income tax expense
-
3,00 мың
27,00 мың
1,00 мың
Effective tax rate
-
-
-0,01%
-
Other operating expenses
-
-
-
-
Net income
-273,50 млн
-420,54 млн
-388,72 млн
-382,53 млн
Net profit margin
-218,21%
-235,00%
-292,65%
-173,53%
Earnings per share
-
-
-
-
Interest and investment income
7,83 млн
11,66 млн
6,03 млн
5,01 млн
Interest expense
-11,41 млн
-11,31 млн
-11,70 млн
-16,53 млн
Net interest expenses
-3,58 млн
354,00 м.
-5,67 млн
-11,52 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-243,08 млн
-370,64 млн
-357,68 млн
-326,85 млн
Gain or loss from assets sale
-21,83 млн
62,12 млн
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары